Diabetes

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The program is expected to discuss a new oral hypoglycaemic agent (SGLT2-inhibitor) for management of feline diabetes

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes

We have compiled a countdown of our top 15 articles in 2023, here is number 15

Check out this week’s headlines

A novel class of drugs normalizes blood glucose in type 2 diabetic cats by dumping sugar into urine rather than modulating glucose uptake in the tissues but patient selection and close monitoring are crucial to using them safely

Jessica Pritchard, VMD, MS, DACVIM (SAIM), discusses the difference between Type 1 and Type 2 diabetes and how it differs in dogs and cats

A discussion on the traditional treatments for feline diabetes, with an introduction to some newer options coming to the market

Fetch Coastal lecturer Liza Wysong, BAS, RVT, VTS (CP-CF, SAIM), describes the discrepancies of this disease in dog and cat patients and the importance of an individualized approach

Akston Biosciences Corporation is working to development drugs to treat diabetes in pets as well as chronic pain in dogs and canine cancers

SENVELGO is a once daily medication to improve glycemic control in cats with diabetes mellitus

Learn and earn 0.25 CE credits online with dvm360 Flex

In this interview, Fetch Charlotte faculty member Dr Natalie Marks emphasizes finding a treatment plan that works for the patient and their caregiver as well

In this interview, faculty member Dr Natalie Marks previews this must-attend session that will take place at the Fetch Charlotte Conference

Improves in-clinic and at-home diabetes monitoring for more informed decisions surrounding patient care

We have compiled a countdown of our top 20 articles in 2022, here is number 14

Understanding the diagnostic dilemmas associated with feline hyperthyroidism and how to resolve these with additional testing

The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.

The earlier pets are diagnosed with diabetes, the greater odds of living long, healthy lives

Heather Kvitko-White, DVM, DACVIM, shared her thoughts on using continuous glucose monitors with diabetic patients.

FGMS may help enhance at-home care and the overall management of veterinary diabetes

Digitail aims to create this software to help pet owners better manage a companion animal’s diabetes.

3 videos featuring insights for treating diabetic patients.